CELLECT BIOTECH/S (NASDAQ:APOP) shares fell 0.4% during mid-day trading on Friday . The stock traded as low as $2.26 and last traded at $2.32, 44,338 shares were traded during mid-day trading. A decline of 93% from the average session volume of 652,198 shares. The stock had previously closed at $2.33.
The firm has a 50 day moving average price of $2.58 and a 200-day moving average price of $1.67. The company has a current ratio of 6.50, a quick ratio of 6.50 and a debt-to-equity ratio of 0.04. The firm has a market cap of $5.24 million, a PE ratio of -1.00 and a beta of 1.74.
CELLECT BIOTECH/S (NASDAQ:APOP) last announced its quarterly earnings data on Tuesday, November 19th. The company reported ($0.61) earnings per share (EPS) for the quarter.
CELLECT BIOTECH/S Company Profile (NASDAQ:APOP)
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. It is developing the ApoTainer selection kit, a shelf stem cell selection kit for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies.
Further Reading: Asset Allocation, Balancing Your Investments
Receive News & Ratings for CELLECT BIOTECH/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CELLECT BIOTECH/S and related companies with MarketBeat.com's FREE daily email newsletter.